Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Engage Grants Program

McGill University

$25,000.00

Development of vascular phantoms for ablation catheter technology optimization

EF 2017-18

Résumé
Cardiovascular diseases affect 36.9% of the population. It is estimated that 4-5 million people are affected byatrial fibrillation (irregular heart beat) in the US and about 350000 in Canada. An important treatment iscatheter ablation of the erratic conductive cells causing the fibrillation, located near the pulmonary veins ostiain the left atrium. Catheter ablation involves the insertion of a catheter in the groin and directed via the venacava into the right atria. The septal wall between the right atrium and the left atrium is punctured to access thepulmonary veins ostia. The catheter tip delivers energy (radio frequency, cryogenic, ultrasound) to isolate theerratic conductive cells. However, catheter ablation is associated with complications rates of about 4.5%including atrio-esophageal fistula, a life threatening condition. Improvement of the technology requires aprecise assessment of the orientation, positioning, contact forces and navigation through the tissue and deliveryof the energy for achieving the desired isolation while avoiding unwanted perforation and burn/freeze. AgileMV is developing an adjunctive device to ablation catheters that has the potential to provide better positioning,reduce associated potential vessel damage while decreasing the intervention time for an improved patientoutcome and lower hospital/physician costs. In this project, we propose to use a methodology that wedeveloped for making anatomically and biomechanically correct hydrogel vascular phantoms to reproduce thespecific anatomy of the left atrium, right atrium and vena cava to optimize the biomechanical parameters ofAgile MV's design to ensure most favorable treatment. We will use an approach that we developed for othervascular structures (ascending aorta, AAA) and customize it for Agile's project by reconstructing the vena cava,right atrium and left atrium. This approach makes uses of PVA (PolyVinyl Alcohol) to reproduce the elasticproperties of vascular tissue. This provides realistic and reproducible vascular phantoms for testinginterventional technology.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
508687-2017
Name nom
Mongrain, Rosaire
Department département
Mechanical Engineering
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2017
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1552
Committee name en
Quebec Internal Decision Committee
Committee name fr
Comité de décision interne pour le Québec
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Partie
1
Nb partie
1
Application title
Development of vascular phantoms for ablation catheter technology optimization
Keyword
NSERC
Application summary
Cardiovascular diseases affect 36.9% of the population. It is estimated that 4-5 million people are affected byatrial fibrillation (irregular heart beat) in the US and about 350000 in Canada. An important treatment iscatheter ablation of the erratic conductive cells causing the fibrillation, located near the pulmonary veins ostiain the left atrium. Catheter ablation involves the insertion of a catheter in the groin and directed via the venacava into the right atria. The septal wall between the right atrium and the left atrium is punctured to access thepulmonary veins ostia. The catheter tip delivers energy (radio frequency, cryogenic, ultrasound) to isolate theerratic conductive cells. However, catheter ablation is associated with complications rates of about 4.5%including atrio-esophageal fistula, a life threatening condition. Improvement of the technology requires aprecise assessment of the orientation, positioning, contact forces and navigation through the tissue and deliveryof the energy for achieving the desired isolation while avoiding unwanted perforation and burn/freeze. AgileMV is developing an adjunctive device to ablation catheters that has the potential to provide better positioning,reduce associated potential vessel damage while decreasing the intervention time for an improved patientoutcome and lower hospital/physician costs. In this project, we propose to use a methodology that wedeveloped for making anatomically and biomechanically correct hydrogel vascular phantoms to reproduce thespecific anatomy of the left atrium, right atrium and vena cava to optimize the biomechanical parameters ofAgile MV's design to ensure most favorable treatment. We will use an approach that we developed for othervascular structures (ascending aorta, AAA) and customize it for Agile's project by reconstructing the vena cava,right atrium and left atrium. This approach makes uses of PVA (PolyVinyl Alcohol) to reproduce the elasticproperties of vascular tissue. This provides realistic and reproducible vascular phantoms for testinginterventional technology.